In a first step towards creating artificial sperm cells, researchers have turned
human bone marrow tissue into primitive sperm cells.
Not exact matches
Then, to boost the number of cells, which is another hurdle in
tissue engineering, the researchers mixed the chondrocytes with
human mesenchymal stem cells from
bone marrow.
The researchers used «humanized mice,» which have had their immune systems replaced with
human immune system cells, thymus
tissue and
bone marrow.
Subsequent transplant of millions of
human T - ALL cells into normal mice that were then treated with an anti-CXCR4 drug induced remission within two weeks, with diseased spleen and
bone marrow tissue nearly returning to normal.
In experiments in mice and
human cells, researchers found that blocking CXCR4 — a so - called homing receptor protein molecule that helps T cells mature and attracts blood cells to the
bone marrow — halted disease progression in
bone marrow and spleen
tissue within two weeks.
To test this idea, the researchers utilized two mouse models of
human breast cancer metastasis and found dormant disseminated tumor cells residing upon the membrane microvasculature of lung,
bone marrow and brain
tissue.
The team hopes to apply this method to the nerve cells,
bone marrow, and brain
tissue of living animals and
humans.
Prior research with cultured
tissue had shown that a mix of chemicals could change
bone marrow stem cells from mice to those resembling brain cells, but when a team led by neurologist Lorraine Iacovitti of Thomas Jefferson University in Philadelphia tried the same brew on
human cells, the number altered was modest.
«Our group pioneered the development of cell culture technology for harvesting large numbers of stem cells from
human bone marrow and
human umbilical cord blood,» Dr. Yeh said, noting that stem cells from these two sources are abundant and can be guided into different types of cells using
tissue engineering.
A team led by researchers at the Tufts University School of Engineering and the University of Pavia has reported development of the first three - dimensional
tissue system that reproduces the complex structure and physiology of
human bone marrow and successfully generates functional
human platelets.
Weian Zhao, associate professor of pharmaceutical sciences, and colleagues have programmed
human bone marrow stem cells to identify the unique physical properties of cancerous
tissue.
David Kaplan, Ph.D., professor and Director of the NIH P41 Resource Center on
Tissue Engineering, Alessandra Balduini, M.D., and their collaborators have focused on forming
bone marrow models with these components and other growth factors to imitate and support the formation of functional
human platelets.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering at Tufts University and their collaborators have successfully developed a 3 - dimensional (3D)
tissue - engineered model of
bone marrow that can produce functional
human platelets outside the body (ex vivo).
Sphingosine -1-phosphate mediates proliferation maintaining the multipotency of
human adult
bone marrow and adipose
tissue - derived stem cells (Retraction of vol 2, pg 199, 2010).
Comparison of
human adult stem cells from adipose
tissue and
bone marrow in the treatment of experimental autoimmune encephalomyelitis.
Sphingosine -1-phosphate mediates proliferation maintaining the multipotency of
human adult
bone marrow and adipose
tissue - derived stem cells.
Identification of common pathways mediating differentiation of
bone marrow - and adipose
tissue - derived
human mesenchymal stem cells into three mesenchymal lineages.
Sphingosine -1-Phosphate Mediates Proliferation Maintaining the Multipotency of
Human Adult
Bone Marrow and Adipose
Tissue - derived Stem Cells (Retracted article.
Since 2005 his group is working on the immunomodulatory activities of
human mesenchymal stem cells isolated from different sources —
bone marrow, adipose
tissue, endometrium, decidua.